Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.65
Bid: 5.00
Ask: 6.30
Change: 0.55 (10.78%)
Spread: 1.30 (26.00%)
Open: 5.10
High: 0.00
Low: 0.00
Prev. Close: 5.10
NOG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing Announcement

18 Jul 2017 07:00

RNS Number : 3118L
Nostrum Oil & Gas PLC
18 July 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA (EXCEPT TO QUALIFIED INSTITUTIONAL BUYERS UNDER RULE 144A OF THE SECURITIES ACT), AUSTRALIA, CANADA OR JAPAN.

 

 

Amsterdam, 18 July 2017 (8:00am CET)

 

NOSTRUM OIL & GAS PRICING ANNOUNCEMENT

 

Disclosure of inside information in accordance with Article 17 of Regulation (EU) 596/2014 (16 April 2014) relating to Zhaikmunai LLP and Nostrum Oil & Gas PLC

 

Nostrum Oil & Gas PLC (the Company), a LSE listed, independent oil and gas producer in the pre-Caspian Basin, rated B2/B by Moody's/S&P, announced today the pricing of its offering of U.S.$725,000,000 8.000% Senior Notes due 2022 (the "Notes"). Citi and VTB Capital acted as Joint Global Coordinators and Joint Bookrunners; and Banca IMI and Deutsche Bank as Joint Bookrunners.

 

The proceeds of the offering will be used, in part, to pay repurchase costs in connection with a tender offer and consent solicitation for both of the outstanding Eurobonds issued by its subsidiary, Zhaikmunai LLP, due 2019, to pay certain fees and expenses in connection with the refinancing, and for general corporate purposes. FCA/ICMA stabilization applies.

 

 

 

This press release (and the information contained herein) is not an offer of securities for sale, or the solicitation of an offer to purchase securities, in the United States ("U.S."). Securities may not be offered or sold in the U.S. absent registration under the U.S. Securities Act of 1933, as amended (the "Securities Act") or an exemption from registration. In the United States this communication is only directed at investors who are "qualified institutional buyers" under Rule 144A of the Securities Act. The securities referred to herein have not been and will not be registered under the Securities Act. No public offering of the securities will be made in the U.S.

 

It may be unlawful to distribute this press release in certain jurisdictions. This press release in not for distribution in Canada, Japan or Australia. The information in this press release in does not constitute an offer of securities for sale in Canada, Japan or Australia or any other jurisdiction.

 

In the United Kingdom this communication is being distributed only to and is directed only at (a) persons outside the United Kingdom, (b) "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC who are (i) persons who have professional experience in matters relating to investments falling within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), or (c) high net worth entities falling within Article 49(2)(a) to (d) of the Order, and (iii) other persons to whom it may be lawfully communicated (all such persons together being referred to as "relevant persons"). The securities are available only to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be available only to or will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this communication or any of its contents.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEKMGMNGNMGNZZ
Date   Source Headline
5th May 20227:00 amRNSFull Year Results for the Year Ending 31 Dec 2021
29th Apr 202212:38 pmRNSResults of General Meeting
29th Apr 20227:00 amRNSNotice of Revised Full Year Results Date
27th Apr 20224:40 pmRNSSecond Price Monitoring Extn
27th Apr 20224:35 pmRNSPrice Monitoring Extension
21st Apr 202211:51 amRNSNotice of Revised Full Year Results Date
13th Apr 20221:46 pmRNSPublication of Circular/Notice of General Meeting
13th Apr 202210:25 amRNSProposed Restructuring & Related Party Transaction
8th Apr 20224:40 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
6th Apr 20223:44 pmRNSRestatement of impairment charge in prior year
22nd Mar 20224:35 pmRNSPrice Monitoring Extension
21st Mar 20224:41 pmRNSSecond Price Monitoring Extn
21st Mar 20224:35 pmRNSPrice Monitoring Extension
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:36 pmRNSPrice Monitoring Extension
28th Feb 20224:41 pmRNSSecond Price Monitoring Extn
28th Feb 20224:37 pmRNSPrice Monitoring Extension
22nd Feb 20229:15 amRNSDirector Declaration
15th Feb 20224:41 pmRNSSecond Price Monitoring Extn
15th Feb 20224:36 pmRNSPrice Monitoring Extension
9th Feb 20224:41 pmRNSSecond Price Monitoring Extn
9th Feb 20224:35 pmRNSPrice Monitoring Extension
7th Feb 20227:00 amRNSReceipt of Consents in respect of Solicitation
4th Feb 20224:36 pmRNSPrice Monitoring Extension
28th Jan 20227:00 amRNSOperational Update for 4Q and FY2021
24th Jan 20224:42 pmRNSSecond Price Monitoring Extn
24th Jan 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20221:46 pmRNSConsent Solicitation relating to Senior Notes
20th Jan 20224:41 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
19th Jan 20225:36 pmRNSRelated Party Transaction update
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:36 pmRNSPrice Monitoring Extension
18th Jan 20224:41 pmRNSSecond Price Monitoring Extn
18th Jan 20224:36 pmRNSPrice Monitoring Extension
18th Jan 202212:26 pmRNSUpdate on accessions to lock-up agreement
5th Jan 20224:36 pmRNSPrice Monitoring Extension
23rd Dec 20214:59 pmRNSLock-up agreement and restructuring terms
21st Dec 20217:00 amRNSStatement regarding recent media speculation
17th Dec 20211:00 pmRNSExtension of Forbearance Agreement
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:35 pmRNSPrice Monitoring Extension
6th Dec 202111:45 amRNSExtension of Forbearance Agreement
6th Dec 20218:36 amRNSTR-1: Notification of major holdings
26th Nov 20214:41 pmRNSSecond Price Monitoring Extn
26th Nov 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20219:00 amRNSExtension of Forbearance Agreement
23rd Nov 20219:00 amRNSRE AGM vote on authorisation to allot shares
16th Nov 20217:00 amRNS9M 2021 Financial Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.